🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Zhenzhen Liu

Shandong Normal University

ORCID: 0000-0002-3878-1258

Also affiliated with Henan Cancer Hospital

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer.

14 citations

Mei‐Juan Tu, Fangwei Han, Zhenzhen Liu, Neelu Batra, Primo N. Lara +4 more

8 citations

Xiaohang Wu, Xi Chen, Yahan Yang, Yuanjun Shang, Shaopeng Liu +26 more

36 citations

Zhijian Duan, Zhenzhen Liu, Chao Zhang, Richard J. Bold, Frank J. Gonzalez +3 more

0 citations

Zhenzhen Liu, Mei‐Juan Tu, Neelu Batra, Huichang Bi, YU Ai-ming +1 more

N/A
0DataRank · unranked
0 citations

Zhenzhen Liu, Tongyi Dou, Ai‐Ming Yu, Mei‐Juan Tu